Skip to main content
Livermore
Livermore
ZHEN

Van Eck Associates Corp

SEC CIK
0000869178
Latest filing
Aug 14, 2026

DGX holding history

Quest Diagnostics Inc in every 13F filed by Van Eck Associates Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DGX overviewAll 13F holders of DGXFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of DGX by Van Eck Associates Corp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−25,977−100.0%Sold outHolders
Q4 202525,977$4.51M<0.1%+174+0.7%AddedHolders
Q3 202525,803$4.92M<0.1%−208−0.8%ReducedHolders
Q2 202526,011$4.67M<0.1%−1,373−5.0%ReducedHolders
Q1 202527,384$4.63M<0.1%+3,186+13.2%AddedHolders
Q4 202424,198$3.65M<0.1%+21,958+980.3%AddedHolders
Q3 20242,240$352.0K<0.1%−18,879−89.4%ReducedHolders
Q2 202421,119$2.89M<0.1%+1,563+8.0%AddedHolders
Q1 202419,556$2.60M<0.1%+17,284+760.7%AddedHolders
Q4 20232,272$313.0K<0.1%−275−10.8%ReducedHolders
Q3 20232,547$311.0K<0.1%+25+1.0%AddedHolders
Q2 20232,522$355.0K<0.1%−12,269−82.9%ReducedHolders
Q1 202314,791$2.09M<0.1%+21+0.1%AddedHolders
Q4 202214,770$2.31M<0.1%−5,241−26.2%ReducedHolders
Q3 202220,011$2.46M<0.1%−6,695−25.1%ReducedHolders
Q2 202226,706$3.55M<0.1%−2,884−9.7%ReducedHolders
Q1 202229,590$4.05M<0.1%+4,185+16.5%AddedHolders
Q4 202125,405$4.39M<0.1%+3,725+17.2%AddedHolders
Q3 202121,680$3.15M<0.1%+2,077+10.6%AddedHolders
Q2 202119,603$2.59M<0.1%+11,878+153.8%AddedHolders
Q1 20217,725$991.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.